Antibodies to mycoplasma pneumonia igm positive. Mycoplasma pneumonia igg

The presence of C. pneumoniae can be diagnosed in various ways. It is not always possible to use methods that detect the virus itself in sputum or mucus on the walls of the larynx to make a diagnosis. It is much easier to take a blood test using the ELISA method, where if there is chlamydia pneumonia in the body, IgA, IgG, IgM antibodies will be detected. These are unique markers indicating the development of the disease. Knowing the interpretation of titers in tests, you can determine the presence of infection, monitor the effectiveness of treatment, or check the patient’s condition after completing a course of therapy.

What do antibodies to C. pneumoniae in the blood tell you?

Class M immunoglobulins (IgM antibodies to chlamydia pneumonia) are the first indicator that the body itself has begun to fight the infection and protective bodies have appeared in the blood. The more there are, the higher the concentration of infection. They usually begin to form 1 to 7 weeks after infection.

If untreated and the disease progresses, titers of IgM antibodies to C. pneumoniae will constantly increase. They still remain in the blood for some time, but do not create lasting immunity and disappear completely over time.

If the analysis is done earlier, then IgM antibodies will not be detected in the blood, but this does not at all deny the presence of the disease. If there are visible symptoms of the disease or the patient’s unsatisfactory state of health, it is necessary to offer to perform another test, which will detect not antibodies to chlamydia pneumoniae, but the viruses themselves.

Class A immunoglobulins (IgA antibodies to chlamydia pneumonia) are an indicator of acute chlamydial infection. They appear a little later than IgM antibodies and can completely replace them or be present in the blood serum at the same time. IgA antibodies to chlamydia pneumonia indicate the presence of infection in the upper respiratory tract. Although these are protective bodies, their strength is not enough to fight the infection, therefore, having identified immunoglobulins A (IgA antibodies to chlamydia pneumonia), it is necessary to begin treatment and periodically monitor its results. When the drug is effective, titers in test results will begin to decrease sharply.

Immunoglobulins of class G to chlamydia pneumoniae indicate a previous disease if, in addition to them, no other groups of immunoglobulins have been identified. When IgA and IgG antibodies to chlamydia pneumoniae are simultaneously present in the blood serum, it means that the disease is no longer treatable and will most likely become chronic unless the medication is changed. The presence of immunoglobulins of both of these groups may indicate persistent chlamydia, inflammatory processes in the lungs, or the presence of autoimmune diseases caused by infection.

Mycoplasma pneumoniae is one of the main respiratory bacterial pathogens causing respiratory tract diseases. The sooner the diagnosis is made and the pathogen is identified, the more effective the treatment will be and the less severe the consequences. For research, secretions from the mucous membranes of the respiratory tract or blood are taken from infected patients. This may include sputum sampling, scrapings from the surface of the laryngeal walls, or bronchoalveolar lavage. The material is collected depending on the suspected areas of spread of the disease in the patient. At temperatures from 2 to 8 degrees, the material is suitable for research throughout the day. At a temperature of about -20 degrees, the collected material is stored for up to a week, maintaining its properties. A pediatrician prescribes tests for children and a therapist for adults. Ingoda, in severe cases of pneumonia, a pulmonologist or infectious disease specialist is involved in treatment.

The most effective, although quite expensive, is the PCR method for detecting the tiny Mycoplasma pneumoniae virus in sputum or other material. The polymerase chain reaction is a fairly effective method with which you can detect a separate section of mycoplasma DNA in the material that is submitted to the laboratory for research and separate it from other sections found in this material. This material is then laboratory multiplied and examined. PCR studies are based on DNA replication. Doctors consider this study to be one of the most reliable for timely detection of the virus in tests - mycoplasma pneumonia. The sensitivity of this method is about 93%, and its specificity reaches 98%.

The second, but no less proven and effective method for studying the presence of mycoplasma pneumonia in the body is the ELISA analysis. Only an enzyme-linked immunosorbent assay is capable of identifying serological markers of IgG and IgM, which are formed against mycoplasma. In this study, the patient’s blood is provided to the laboratory as a material, then the blood serum is separated to detect class M or G antibodies in it.

Test results depend on the presence of the virus in the material being tested. Mycoplasma pneumonia in the presence of IgG antibodies will be positive if the number in titers is more than 20 OU/l. This indicates a current infection or a recent illness with the residual presence of antibodies in the material. A group of IgG antibodies to mycoplasma is formed approximately two weeks after the infection has entered the body. They can be detected in the blood for 2 years even after the disease is completely cured.

The test is considered negative when the amount of IgG antibodies is less than 16 FU/l. With such titers, the disease is absent or the analysis was taken at a very early stage, when antibodies to mycoplasma pneumonia IgG had not yet begun to form. To make a final diagnosis, the material is re-examined. If the patient's condition does not improve after two weeks and titers increase, disease progression should be considered.

The presence of IgM antibodies to mycoplasma indicates early detection of the disease. At later stages, these specific immunoglobulins may no longer be visible in tests, but this does not indicate the absence of mycoplasma. Doctors usually look at the total value of these quantities.

Antibodies of the LgG group for mycoplasma pneumonia indicate the presence of chlamydia in the patient.

Each patient must be notified that he will have to undergo a PCR or ELISA test to determine the diagnosis. Although these studies do not require any special preparation, you should still know that:

• For ELISA analysis to determine antibodies of groups LgG, IgG, IgM, only venous blood is taken.
• Patients are prohibited from smoking before donating blood (30 minutes).
• Patients are required to tell their doctor if they have an autoimmune disease.

It has been noted that children and young people under the age of 30 are more susceptible to infection with this infection. Most often, virus infections occur in large cities, where groups of people gather. Mycoplasma pneumonia accounts for 1/4 of all pneumonia.

Mycoplasmas do not have their own devices to synthesize energy, so they use the resources of the cells they infect to live and reproduce. This is due to a number of factors:

• they are small in size and live inside infected cells. In addition, pathogens have a similar structural structure to elements of normal healthy tissue. These factors make it possible to hide them from the influence of the immune system and reduce sensitivity to antibiotics;
• pathogens are mobile, therefore, if one cell is destroyed, they move to others and infect them;
• they are very firmly attached to the cells, which allows mycoplasmosis pneumonia to occur even if a small number of pathogens have entered the body.

Mycoplasma is sensitive to ultraviolet irradiation and sudden changes in temperature, so they cannot exist in the external environment for long. In 90% of cases, infection occurs through airborne transmission. This virus often catches on to children in kindergarten or school. The greatest chance of infection is during the cold season.

Symptoms of mycoplasma pneumonia in adults and children

The incubation period of the disease varies from 10 to 20 days. During this period, mycoplasma pneumonia almost always does not manifest itself in any way. The peculiarity of the course of pneumonia caused by mycoplasma is that it can last 4-5 weeks, and in some cases, several months.

Mycoplasma pneumonia manifests itself differently in adults than in children. The most common symptoms in adults are:

• prolonged cough with copious production of viscous sputum. In exceptional cases, it can develop into a chronic form and persist for up to 5 weeks;
• hoarseness of voice;
• headache;
• nasal congestion;
• dermatological diseases (erythema multiforme);
• increased sweating;
• enlarged lymph nodes in the neck;
• pain in joints and muscles;
• deterioration of general physical condition.

According to statistics, mycoplasma pneumonia in children aged 3-6 years is more common and manifests itself with more pronounced symptoms:

• regular migraine attacks;
• the appearance of severe chills with a slight increase in temperature;
• impaired coordination of movements;
• the occurrence of a feverish state;
• the appearance of a painful dry cough.

Complications of the disease

In the absence of timely treatment, the disease can lead to such serious complications as a purulent-destructive limited process in the lungs (lung abscess), inflammation of the brain or joint, and a low level of hemoglobin in the blood. In older people, due to weakened immunity, the disease may be accompanied by temporary inflammation of the peripheral nerves, which leads to severe muscle weakness.

Important!!! Mycoplasma pneumonia in an advanced stage can be fatal, so if similar symptoms occur, consult a doctor immediately.

In preschool children, complications manifest themselves differently:

• Digestive disorders (diarrhea and vomiting) occur in 35% of cases of infection by the bacterium Mycoplasma pneumonia;
• in most cases, children are affected by hemorrhagic diathesis localized on all extremities. They usually disappear on their own on the 7-10th day of illness;
• In rare cases, inflammation of the heart muscle or joint damage (arthritis) may occur.

Diagnosis of the disease

To diagnose the disease, the patient should consult an infectious disease specialist or pulmonologist. At the initial examination, the doctor collects anamnesis and listens to the patient with a phonendoscope; with pneumonia, wheezing will be heard in the patient’s lungs. The symptoms of mycoplasma pneumonia are similar to many other diseases of the respiratory system (for example, influenza or chronic bronchitis), therefore, to make an accurate diagnosis, the doctor prescribes a series of diagnostic and laboratory tests for the patient.

Among diagnostic studies, preference is given to radiography and computed tomography. They allow you to see an intensification of the pulmonary pattern with small focal shadows mainly in the lower parts of the lungs.

Of the molecular biological studies for diagnosing mycoplasmosis pneumonia, the most accurate are:

• determination of DNA of Mycoplasma pneumoniae bacteria. Most often, material for PCR is taken from the throat (smear), less often it is sputum or blood. An important advantage of the method is the short analysis time, which is especially important for speedy diagnosis and treatment;
• general blood analysis. During the inflammatory process, the analysis shows an increased content of leukocytes in the blood;
• allergy diagnostics (determination of specific antibodies IgG, LgA and IgM). When the body becomes infected with an infection, the immune system produces antibodies. IgM to Mycoplasma pneumoniae appears in the blood 2-3 days after the onset of the disease, while anti-mycoplasma pneumoniae IgG begins to increase 1-2 weeks later and can remain in the blood for a long time after complete recovery. It is recommended to diagnose the titer of all antibodies. If the tests reveal a positive IgM titer, then the person was infected with mycoplasma in the coming days; if only the IgG titer is positive, the pathogens entered the body a long time ago, but have now managed to get rid of them. If the test shows both positive results, there is an infection and treatment should be started as soon as possible. IgA pneumonia does not apply to mycoplasma pneumonia; if a positive titer is detected, then the patient is a carrier of mycoplasma homins (the causative agent of urogenital mycoplasmosis).

Treatment and prevention of the disease

If you consult a doctor in a timely manner, the treatment prognosis is favorable. The treatment regimen is selected individually depending on the stage of the disease and the symptoms manifested. If the disease occurs in an acute stage, then therapeutic assistance is provided, where patients are prescribed bed rest. The patient will be able to see the effectiveness of treatment after 5-10 days of therapy, but it will be possible to achieve complete recovery of the body in about 3 weeks.

As a rule, the disease occurs with a severe cough, so a specialist may prescribe antitussives and expectorants (for example, ambroxol). Antibiotic treatment is aimed at eliminating the causative agents of the disease. The first days they are administered intravenously and then orally. The general course of antibiotic therapy usually lasts at least 14 days. The following antibacterial drugs are most effective: erythromycin, ciprofloxacin, clarithromycin. For children, doctors prescribe special macrolide antibiotics because they are the safest. Hormones in the treatment of mycoplasma pneumonia are prescribed only in advanced cases when antibacterial therapy does not bring visible results.

Important!!! There is a high resistance of Mycoplasma pneumonia to antibiotics of most types. The drug must be prescribed by a specialist.

The disease should be treated comprehensively; it is recommended to add a complex of therapeutic physical exercises, physiotherapeutic procedures and massage (during the recovery period) to drug treatment. Since mycoplasmas cause damage not only to the lungs, but also to the upper respiratory tract, it is important to regularly gargle and flush out the sinuses.

Additionally, you can use folk remedies to increase the effectiveness of drug therapy and speed up the recovery process. They have an anti-inflammatory effect, help relieve local symptoms and help strengthen the immune system. Consider recipes for popular infusions and decoctions:

• To prepare the infusion, take medicinal herbs - St. John's wort, chamomile and cornflower in an equal ratio of 1:1:1. All components are crushed, 2 tablespoons are poured into a container and 500 ml of hot water is poured. Leave to infuse in a dark place for 60-90 minutes, then filter. It is recommended to use the resulting product 150 ml at least 3 times a day.
• Inhalations with decoctions of medicinal herbs are very effective in treating respiratory diseases. You can use the recipe with the previously described components, adding pine needles and eucalyptus to them. Inhalation can be carried out daily for 8-12 minutes 1-2 times a day.
• Blackberry infusion strengthens the immune system and helps with inflammatory diseases of the respiratory tract. 2 tablespoons of blackberry leaves are poured into 400 ml of boiling water. When the infusion has cooled a little, it can be consumed. The amount received is enough for 4 doses per day.

Important!!! To avoid allergic reactions to natural ingredients, consult a specialist in advance.

As preventive measures, it is recommended, if possible, to avoid places with large crowds of people during epidemic outbreaks (or wear protective masks), drink immune-strengthening drugs 1-2 times a year, and maintain personal hygiene. Maintaining proper nutrition has a positive effect on health, so it is advisable to add as many vegetables, meat and fruits (high in beneficial microelements and vitamins) to your diet. If the patient has chronic diseases of the respiratory system, it is important to follow up with a pulmonologist for several months after recovery.

It is an infectious disease of the respiratory system that is caused by pathogenic microorganisms. Determining the type of pathogen is of great importance in the diagnosis and treatment of the disease, since each of them is sensitive to a certain category of drugs. Most often, the pathological process is caused by pneumococci and staphylococci, but other types of bacteria are also found, in particular mycoplasma pneumonia. What is pneumonia caused by this pathogen, and how to treat it?

Mycoplasma is a bacterium that can cause genitourinary and respiratory infections. The list of varieties of this microorganism includes mycoplasma pneumoniae, which causes respiratory mycoplasmosis.

The bacterium is usually transmitted by airborne droplets, but the endogenous route of infection is also encountered. Mycoplasma is present in the body of every person, and under favorable conditions (immunodeficiency states, pathologies of the respiratory system, tumor processes of the blood) begins to actively multiply. This type of disease is diagnosed in 20% of people with pneumonia, and most often it affects children under 5 years of age and young people, and in patients over 35 it is observed quite rarely.

The incubation period of mycoplasma pneumonia is from 1 to 3 weeks, symptoms resemble those of the flu or pharyngitis, and include:

• temperature rise to 37-37.5 degrees;
• sore throat, dry cough;
• nasal congestion;
• headaches, muscle and joint pain;
• skin rash;
• enlarged lymph nodes;
• deterioration in general health.

As a rule, symptoms increase gradually, but there is an acute onset of the disease with manifestations of intoxication of the body. A characteristic sign of mycoplasma pneumonia is a dry, debilitating cough with the release of a small amount of viscous sputum. It lasts for at least 10-15 days after infection of the body, and sometimes can last up to 4-6 weeks, since mycoplasma causes obstruction of the respiratory tract.

IMPORTANT! Mycoplasma pneumonia belongs to the category of atypical forms of the disease, and usually occurs in a severe form - due to the special structure of the bacterium, which resembles the structure of the cells of the human body, antibodies to it begin to be produced quite late.

How to determine the disease

Diagnosis of mycoplasma pneumonia requires special attention, since the signs of the disease resemble those of other respiratory infections. To identify the pathogen and make an accurate diagnosis, a number of instrumental and clinical studies are required.

1. External examination and listening of the chest. The classic manifestations of pneumonia (fever, cough) in the mycoplasma form of the disease are not too pronounced, but extrapulmonary symptoms are present - skin rash, muscle and joint pain, sometimes pain in the ears and eyes. When listening to the chest, rare medium or fine bubbles are heard, which indicates the presence of fluid in the lungs and bronchi.
2. , MRI, CT. The X-ray shows a noticeable increase in the pattern of the lungs with typical foci of infiltration for the disease, which, as a rule, are located in the lower part of the lungs. Sometimes, to clarify the diagnosis and identify concomitant pathologies, computed tomography or magnetic resonance imaging is required.
3. General blood analysis. A clinical blood test determines moderate leukocytosis and a slight increase in ESR (with mycoplasma pneumonia, signs of a pathological process in a general blood test are less pronounced than with pneumonia of bacterial origin).
4. PCR. The polymerase chain reaction, or PCR method, is one of the most informative ways to detect mycoplasma pneumoniae in the body. It allows you to find fragments of pathogenic microorganisms in the material under study (a sample of a patient’s venous blood), isolate them from others and multiply them, which allows you to accurately determine the causative agent of the pathological process.

REFERENCE! Other methods that are used to identify other forms of pneumonia (for example, sputum examination) are not used for mycoplasma pneumonia, as they have no diagnostic value.

Antibodies IgA, IgM and IgG if detected

After Mycoplasma pneumonia enters the respiratory tract, the body begins to produce specific immunoglobulins, which can be detected by ELISA (enzyme-linked immunosorbent assay).

This is the most informative diagnostic method, which allows you to determine not only the presence of the disease, but also the features of its clinical picture - acute, chronic form or re-infection.

There are three types of antibodies that can be tested positive to determine the presence of infection - IgA, IgM and IgG, what does this mean?

Immediately after infection, the production of IgM immunoglobulins begins, and after 5-7 days - IgG antibodies, and their level remains elevated longer than the IgM titer, and during recovery it decreases significantly. The production of IgA proteins begins last, after the appearance of IgG, and continues for a year or more.

To make an accurate diagnosis, immunoglobulins IgM and IgG are detected; it is recommended to take the test 1-4 weeks after the onset of the disease at least twice (a single measurement of antibody levels does not give a reliable result). The presence of the disease is indicated by a dynamic increase in the level of IgM antibodies, as well as an increase in the concentration of IgG proteins in samples taken sequentially at intervals of at least 2 weeks. An increased titer of IgA immunoglobulins indicates an acute or chronic course of mycoplasma pneumonia, as well as re-infection.

IMPORTANT! Diagnosis of the pathological process caused by mycoplasma pneumonia must be comprehensive and include anamnesis collection, analysis of symptoms and complaints, as well as determination of IgM and IgG antibodies.

Healing methods

Pneumonia caused by mycoplasma can lead to serious complications, so treatment should be started immediately after diagnosis. The basis of treatment in adults and children is, as a rule, from the group of macrolides, but in the presence of contraindications and allergic reactions, drugs from other groups can be prescribed, and the course lasts at least 2 weeks.

Along with antimicrobial agents, doctors prescribe antipyretics, painkillers, antihistamines, etc. In addition, patients need bed rest, a diet high in vitamins and microelements, and drinking plenty of fluids.

During the recovery period, special attention should be paid to rehabilitation measures - massage, therapeutic exercises, walks in the fresh air, spa treatment. This is especially true for children, the elderly and patients who have suffered a severe form of pneumonia, accompanied by deterioration of respiratory function.

Chlamydial pneumonia can be caused by several types of microorganisms, which cause different manifestations in children and adults. Chlamydia pneumoniae or Chlamydophila pneumonia are most often involved in the pathogenesis.

Photo from ru.wikipedia.org

Chlamydia pneumoniae causes upper respiratory tract disease and pneumonia in children. The question of the possible influence of this pathogen on the occurrence of bronchial asthma and autoimmune diseases is discussed.

Clinical symptoms in children most often develop from symptoms of acute viral infection. Chlamydial pneumonia is an atypical form, and is initially disguised as the following diseases:

• pharyngitis;
• rhinitis;
• laryngitis;
• sinusitis;
• bronchitis;
• otitis.

Against this background, symptoms appear: increased body temperature, malaise, muscle pain, weakness, and chills are not typical. A dry, paroxysmal cough that turns into a productive cough with a small amount of mucopurulent sputum should be alarming. Mild symptoms often make it difficult to diagnose pneumonia, which prevents timely treatment from starting.

Infection in children and newborns

In children under 6 months of age, chlamydia pneumonia is transmitted “vertically” from an infected mother in utero or during passage through the birth canal. Symptoms of infection combine symptoms of conjunctivitis with inflammation of the upper respiratory tract.

The progression of bronchitis symptoms without specific treatment leads to pneumonia. In primary and secondary school age, the most common causative agent of atypical infection is chlamydia pneumonia.

Diagnosis of the disease

Given the erased symptoms, it is extremely difficult to suspect this type of inflammation. The standard set of changes in the lungs does not allow an accurate diagnosis:

1. Percussion does not reveal pronounced changes;
2. Auscultation - dry or fine bubbling wheezing, scattered, mainly in the lower parts;
3. X-ray examination - often there are no changes; interstitial opacities or small focal pneumonia are possible.

A general blood test against the background of symptoms of pharyngitis and rhinitis will show an increase in ESR and a decrease in the level of leukocytes.

Chlamydia is diagnosed in children and adults with weakened immune systems by serotyping and identifying specific IgA, IgM and IgG. Antibodies to chlamydia pneumonia appear two weeks after the bacteria begin to persist in the human body.

Diagnosis is based on an increase in IgA >1:256, IgM >1:16 and IgG >1:512 in peripheral blood. Also, an increase in titers in paired sera by more than 4 times is a positive result.

The stage and nature of the disease are determined by the level of IgA, IgM and IgG antibodies over time and their combination.

IgM level value

The detection of IgM antibodies indicates that the body begins to fight the infection and produces protective cells. The higher the IgM level, the more active the inflammatory process. Detection of class M immunoglobulins is possible as early as 1 week after the first symptoms appear.

Without specific treatment, the titer of IgM antibodies constantly increases, but does not indicate the presence of stable immunity. Over time, IgM completely disappears from the blood.

Immunoglobulins class A

Appear during acute chlamydial infection. IgA appears somewhat later than IgM and can be detected as the only antibody or in combination with IgM. Determination of the antibody titer of a given type is used to evaluate treatment. With properly selected therapy, IgA levels will decrease sharply.

IgG level indicators

IgG – antibodies to chlamydia pneumonia, which indicate stable immunity and recovery. IgG immunoglobulins can be detected in children for three years after suffering from pneumonia with a favorable outcome.

The most unfavorable is the detection of a combination of IgG with IgA and IgM. If an increased titer of IgG and IgA is detected in peripheral blood by ELISA, this indicates the ineffectiveness of therapy and possible chronicity of the infection.

Repeated detection of high levels of IgG and IgA immunoglobulins raises suspicions of persistent chlamydia or an autoimmune disease caused by chlamydia.

Treatment of chlamydia pneumonia

It is necessary to treat pneumonia caused by chlamydia with modern antibiotics of the latest generations. Depending on age, tetracyclines, macrolides or fluoroquinolones are prescribed. Of course, powerful symptomatic therapy and general strengthening measures are added.

With severe symptoms of intoxication, it is better to treat pneumonia, especially in young children, in a hospital.

Despite the modern level of medicine, up to 9% of chlamydial infections are fatal. This is due to the erased symptoms of the onset of the disease and the late detection of chlamydia. Only adequate treatment in newborns and children will allow for complete recovery, which must be confirmed by IgG titers in the blood.